International Business


Incepta, a leading Pharmaceutical manufacturer in Bangladesh, continues its voyage towards the inherent dream to become a key contributor in the world Pharmaceutical market by maintaining a constant commitment to research, develop innovative products and quality management. Our unwavering determination to achieve excellence leads us to new global benchmarks.

Incepta is guided by its export mission to improve the health and well-being of people across the world. Its corporate philosophy is to create new values around health-related products through science and advanced technology.

The company is dedicating a significant percentage of its resources to strengthen its technology including biotechnology, centered on Pharmaceuticals. Incepta currently manufactures and sells several bio-tech products in the local market. In order to expand its bio-tech business abroad, Incepta has already established a state-of-the-art Human Vaccine production facility which became the first Bangladeshi company to export vaccines.

Within eleven years of starting export operations, Incepta now sells its products in 67 countries. This has become possible due to an intellectual pool consisting some of the best minds in the country. Starting in 2006, Incepta has already registered more than 800 products in different countries around the globe. Further negotiation with possible business partners and product registration is going on to establish the presence of the company in many more countries. 

In January 2008, the company received "Certificate of GMP compliance" from European Union which basically opened the door to the European market for Incepta.

UK MHRA, the regulatory authority of England has inspected the Zirabo plant of Incepta Pharmaceuticals Ltd in February 2011. Incepta received the GMP approval for its solid dosage form facility in July 2011 for its own formulated products allowing marketing in UK and other European countries.

In 2004, Incepta was inspected by UNICEF and UNDP and accepted as a potential supplier. In 2005, Incepta started supplying products to UNICEF locally in Bangladesh. Subsequently in 2010, Incepta was accepted by the global headquarters of UN agencies at Copenhagen, Denmark and became enlisted as global supplier to UNICEF, UNESCO, UNDP, UNRWA and UNFPA.

During the course of the last couple of years the company has received accreditation from many other countries of the world and currently holds the following GMP certificates from their respective Ministry of Health.

  • UK MHRA GMP Certificate
  • Health Canada GMP Certificate
  • Germany GMP Certificate
  • Turkey GMP Certificate
  • Taiwan GMP Certificate
  • Philippines GMP Certificate
  • Moldova GMP Certificate
  • Yemen GMP Certificate
  • Kenya GMP Certificate
  • Uganda GMP Certificate
  • Democratic Republic of Congo GMP Certificate
  • Ethiopia GMP Certificate

Incepta currently sells its product in many countries of Asia, Africa, Central America, Latin America and Europe and is taking special efforts to ensure presence in the rest of the globe. Currently the company is exploring distributorship, contract manufacturing, in licensing, technology partnership and many other forms of cooperation. Companies around the world can benefit from partnership with Incepta as the company offers a very large portfolio of generic products to choose from. Focus on ensuring high quality and cost effectiveness makes our portfolio more attractive to potential customers.